Oct 19 2026 | By: Burzynski Clinic
Cancer biomarker testing looks for genes, proteins, or other substances that can provide information about a tumor. Some findings may help guide treatment or clinical-trial discussions, while others do not have a proven action. Results should be interpreted with the cancer type, pathology, stage, prior treatment, current health, and strength of evidence.
This article is educational and does not provide individualized medical advice. A qualified clinician should interpret records, tests, risks, and treatment options for the specific patient.
The National Cancer Institute defines biomarker testing as a way to look for genes, proteins, and other substances that can provide information about cancer. The test may use tumor tissue, blood, or another sample. The report may identify variants, expression levels, or other findings.
Actionable generally means that a result may influence a clinical decision. That influence can take different forms: an approved treatment for that cancer, an approved treatment in another setting, a clinical trial, additional testing, or no current treatment action. The report language and evidence level matter.
A molecular finding cannot be interpreted in isolation. The same biomarker may have different implications in different cancers. Prior therapies, organ function, medications, overall health, treatment goals, and access also affect whether an option is appropriate.
Ask whether the sample was adequate, whether the test examined tumor tissue or blood, which findings are clinically meaningful, how strong the evidence is, whether a therapy is approved for this situation, and whether a trial is available. Also ask what the test could not determine.
Burzynski Clinic reviews medical records before an initial consultation is scheduled. The clinic's prospective patient process lists the records recommended for evaluation and explains how patients may provide records or authorize the clinic to request them. Initial consultations take place in person at the Houston clinic.
Burzynski Clinic is located at 9432 Katy Freeway, Houston, Texas 77055. Stanislaw R. Burzynski, MD, PhD, Founder. Learn about diagnostic and monitoring services or call 1-713-335-5697 for United States and international inquiries.